Introduction
Interest in halogenated benzimidazole nucleosides stems in large part from the fact that 5,6-dichloro-l-/?-D-ribofuranosylbenzimidazole (DRB) is a speific and reversible inhibitor of nuclear RNA synthesis [1] [2] [3] and a superinducer of interferon production in human fibroblasts [4] , Some bromo derivatives of benzimidazole nucleosides also exhibit enhanced biological activity relative to the corresponding chloro derivatives [4] . It consequently appeared of interest to synthesize, and examine the physico chemical and biological properties of, additional analogues of DRB, including brominated deriva tives.
One pertinent aspect of the foregoing is the relationship of the biological activities of benzimida zole nucleosides to their conformations, the latter of which may be determined with the aid of NMR Reprint requests to Dr. Zygmunt Kazimierczuk. 0341-0382/81/0100-0126 $01.00/0 spectroscopy (for review, see 5) . In the present study we have applied for this purpose a procedure pre viously described [6, 7] , based on a comparison of the chemical shifts of the sugar protons in nucleo sides and nucleotides relative to the chemical shifts of the corresponding protons in models fixed in the syn and anti conformations, to determine the confor mation about the glycosidic bond. This required the synthesis of model benzimidazole nucleosides with a bulky substituent at C(2), which would be expected to sterically constrain the aglycone to the conforma tion syn; and a nucleoside with a bulky substituent at C(7), to constrain the aglycone to the conforma tion anti. The synthesis of the 4,6-dibromo and 5,7-dibromo analogues of l-/?-D-ribofuranosylbenzimidazole was based on the procedure of Niedballa & Vorbruggen [12] . The reaction of 4,6-dibromobenzimidazole with the blocked ribose, because of the non-symmetrical structure of 4,6-dibromobenzimidazole, led to a mixture of the isomeric 4,6-and 5,7-dibromo nu cleosides (Scheme 1), as shown by NMR spectros copy. It proved possible to fractionate these by chro matography on Amberlite XAD-4 [13] , which has hitherto been little profited from, but which we have found extremely useful for chromatography of both nucleosides and nucleotides [14] .
Results and Discussion

Syntheses
In surprising contrast to the foregoing, the reac tion with l-0-methyl-2,3,5-tri-0-benzoyl-D-arabinofuranose led to formation of a single product, identi fied unequivocally as the 4,6-dibromo derivative by NMR spectroscopy.
Nucleoside conformations
Analysis with the aid of JH NMR spectroscopy was employed to determine the conformations of the various nucleoside analogues.
Conformation o f sugar rings. The values of the chemical shifts of the sugar protons, and the vicinal proton-proton coupling constants, are listed in Table 1 .
Analysis of the conformation of the sugar rings was based on the two-state model [15] , with a dyna mic equilibrium between the two conformers N, C(3')endo and S, C(2')endo. The results point to a predominance of the form S, from 50% to 75% (Table I) . Marked changes in this range result from:
(a) Introduction of a substituent at C(2) of the benzimidazole ring, leading to an increase in popu lation of the S conformer of up to 12%.
(b) Introduction of a bromine substituent at C(7) of the benzimidazole ring, leading to a decrease in population of the S form of 13%. At the same time the benzimidazole ring is sterically constrained to the form anti (see below). (c) A change in solvent medium. Transfer of the nucleoside from (C2H3)2SO to C2H30 2H results in a decrease in the population S of up to 10%.
K > oo
Introduction of a halogeno substituent at C(4), C(5) and C(6) of the benzimidazole ring, or replace ment of the exocyclic 5'-OH by halogen, is virtually without effect on the sugar ring conformation.
In general the N and S conformer populations of the benzimidazole-/?-riboside analogues are similar to those for the corresponding purine /7-nucleosides, adenosine and guanosine. As in the case of the 8-substituted purine nucleosides, a 2-substituent leads to an increase in population of the S conformer. The similar values for the m oidal coupling constants, and for the sums J (l',2') -I-7(3',4'), in both classes of compounds unsubstituted at the position C(2) or C(8), points to similar puckering of the sugar rings, Tm = 37°, and similar values of the pseudorotational angles, viz. NP = 20° and SP = 165°.
Introduction of substituents at C(2) in the benz imidazole nucleosides, or the corresponding C(8) in purine nucleosides, results in a characteristic in crease in the value of J (2',3') by 0.5-1.0 Hz. The sum J(V ,2 ')+ J (3 'A ') for the benzimidazole ribo sides increases by about 0.5 Hz, whereas it is un changed for the purine nucleosides or is slightly diminished relative to the unsubstituted parent nu cleosides. These effects, although small, are at the moment difficult to interpret, since they may be due to some deformation of the sugar ring (e. g. flatten ing) and/or changes in the phase angles of pseudo rotation NP and SP.
Conformation o f the exocyclic groups. These con formations were determined in the same way as for the corresponding nucleosides [16, 17] , assuming a dynamic equilibrium between three classical conformers, gauche-gauche, gauche-trans and transgauche. The values for the gauche-gauche conformers, the populations of which are predominant, are exhibited in Table I . For most of the nucleosides, the closely similar values for the chemical shifts of H(5') and H(5") rendered difficult estimates of the populations of the other two conformers. The pre dominance of the gauche-gauche populations, from 60% to 80% (Table I) , is similar to that for the cor responding purine /2-nucleosides.
Conformation o f the heterocyclic base
We have previously shown that the populations of the syn/anti conformers in purine nucleosides may be evaluated by measurements of the chemical shifts of the H(2') proton relative to those for model nucleosides fixed in the syn and anti conformations [6, 7] .
As in the case of purine nucleosides, the 2-methyl and the 2-a-hydroxybenzyl nucleosides may, to a first approximation, serve as models in the syn con formation. An examination, with the aid of CPK models, showed that, as in the case of 8-methyladenosine [6] , these substituents are not bulky enough to fully exclude the presence of a small pro portion of the form anti (but see below). By con trast, CPK models demonstrated, in accordance with expectations that, for the 5,7-dibromo substituted nu cleoside, the steric hindrance of the 7-bromo with the pentose ring in the conformation syn is suffi ciently severe as to exclude this form, so that this nucleoside is a good model for the form anti.
The conformations of the various nucleosides were then evaluated by analyses of the chemical shifts of H (l') and H(2') and, independently, by ex aminations of the chemical shifts of the benzimida zole H(4), H(5), H(6) and H (7) protons.
Chemical shifts o f sugar protons. For the 2-methyl and 2-a-hydroxybenzyl-nucleosides, the chemical shifts of H (l') differ by 0.1 -0 .2 ppm from those for the other nucleosides, with the discrepancies being in the range 0.03 ppm (Table I) . This is obviously due to the anisotropic and electrostatic effects of the C(2) substituents which, in the conformation syn, are in the vicinity of H (l').
A characteristic feature is the pronounced devia tion of the chemical shift of H(4') in the 2-a-hydroxybenzyl nucleoside from that for the other nucleo sides, as high as 0.2 ppm in methanolic solution (whereas the chemical shift of H(5') is unaltered). This effect is due to the hydroxybenzyl substituent, which may rotate freely about the single bond to C(2), permitting of its close approach to H(4'), but only when this nucleoside is in the form syn. The foregoing two derivatives may consequently serve as models in the syn conformation.
The strong deshielding, by 0.8 ppm, of H (l') in the 5,7-dibromo nucleoside is readily interpretable in terms of the anisotropic affect of the C(7) bromine substituent on H (l') in the conformation anti, pointing to the validity of the use of this nu cleoside as a model in the form anti.
The values of the chemical shifts for H(2') in ribofuranosylbenzimidazole and its 5,6-dichloro analogue are identical with those of the correspond ing 2-a-hydroxybenzyl and 2-methyl nucleosides in the model form syn, Introduction of bromine sub stituents at C(4), C(5), C(6), or chlorine substituents at C(5), C(6), decreases the value of the chemical shift of H(2'), at most by 0.04 ppm, to a value equal to (5H(2') in the 5,6-dichloro-2-methyl nucleoside. By contrast, introduction of bromine substituents at C(5), C(7), forcing the nucleoside into the anti con formation, increases the value of the chemical shift of H(2') by 0.13 ppm relative to that for the 5,6-dichloro-2-methyl analogue. It may therefore be con cluded that benzimidazole riboside, and its 5-bromo-, 6-bromo-, 5,6-dibromo-, 5,6-dichloro-and 4,6-dibromo-derivatives all exhibit a preference for the conformation syn in DMSO and methanol. How ever, a change in conformation from syn to anti with the benzimidazole nucleosides leads to only small changes in chemical shifts of H(2'), as contrasted to the corresponding marked changes with purine nu cleosides (0.5-0.6ppm , see ref. [6] ). As a result of this, it is difficult to quantitatively evaluate the pro portions of the syn/anti conformers for the benzimi dazole nucleosides. It is feasible, at best, to indicate only whether there is a preference for the form syn, but not to fully exclude some involvement of the form anti.
The differences in the values of <5H(2') of the various analogues are most likely due to the dif ferences in the values of the glycosidic torsion angle assumed by each of them in the conformation syn. The differences in <5H(3'), up to 0.05 ppm, do not exhibit the same regularity as <5H(2'), i. e. they are of the same order of magnitude in going from the form syn to anti as for those analogues in the form syn. Most likely these also derive from differences in the glycosidic torsion angles.
Chemical shifts o f benzimidazole protons. These further support the assignment of the preference for the conformation syn for all the foregoing nucleo sides, with the exception of the 5,7-dibromo analogue. Table II lists (7) do not exhibit this regularity in the ^-ribosides, the deviation from the expected value of 0.1 ppm (for the other protons) being as high as 0.5 ppm. In the a-arabinosides, the changes in <5H(7) are close to 0.1 ppm. It follows that the H(7) proton in the ^-ribosides is located in a different chemical environment than the remaining protons and also different from that in the aglycone itself, /. e. it must be located in the direct vicinity of the sugar ring in the conformation syn.
Furthermore, the changes in the chemical shifts in the various analogues testify to differences in the glycosidic torsion angles, so that H (7) is located in different analogues at differing distances from the sugar ring oxygen.
The changes in <5H(2) are similar in different analogues, viz. deshielding by about 0.25 ppm on introduction of the ribose ring at N (l), except for the 5,7-dibromo derivative, where it is 0.49 ppm. Since the latter has the conformation anti, the re mainder must be preferentially syn.
Analogous conclusions may be drawn from an analysis of the effect of replacement by a halogen of the other protons in the benzimidazole ring. In the parent benzimidazoles, which are symmetrical sys tems, the changes in chemical shifts of H(4) and H(7), on introduction of substituents at C(5) and C(6), are identical. In the /?-ribosides, on the other hand, while the effect on H(4) is similar to that for the parent aglycone, the changes in <5H(7) deviate from these values (by as much as 0.5 ppm). Simi larly in the 4,6-dibromo analogue, the change in <5H(7) in the aglycone differs from that for the ß-riboside. These differences are not due to a distur bance of the symmetry of the system by the sugar ring, since the effects of halogen substituents on H(4) and H(7) in the /?-arabinosides are closely similar (in the range 0.05 ppm). The results therefore indicate that, in the /?-ribosides, the changes in chemical shifts of H(7) are the additive changes in chemical shifts (ASH, in ppm) o f the benzimidazole protons as a result o f the substitution: (a) o f a sugar on the position N (l); (b) resulting from halogen substitution and changes in the glycosidic torsion angles in the syn conformation. The conformation of l-(/?-D-ribofuranosyl)-benzimidazole in liquid N2H3 and 2H20 has been pre viously investigated, applying an analysis of cou pling constants to determine the conformations of the sugar ring and the exocyclic carbinol group, and measurements of relaxation times (7\) of protons, together with the Overhauser effect, to determine the conformation about the glycosidic bond [18] . From these, and our results in DMSO, it appears that the sugar conformation is similar in different solvents, with a population of 55-65% of the form S at room temperature. A somewhat larger variation is observed for the gauche-gauche population of the exocyclic group, from 55% to 75%. Both the relaxa tion methods [18] , and the chemical shift procedure employed in this study, indicate a marked prefer ence for the syn conformation about the glycosidic bond. The 70% population value for the form syn calculated from the relaxation method is probably subject to considerable error, as discussed in detail elsewhere [7] . The chemical shift method in this in stance does not provide accurate results, and predicts a syn population close to 100%; but it is not capable of excluding the presence of a proportion in the form anti of as much as 20%.
The benzimidazole /?-riboside analogues are conformationally similar to the corresponding purine ß -ribosides. The one clear difference relates to the conformation about the glycosidic bond. Purine nu cleosides exhibit a marked preference for the con formation anti [6, 7] , but not to the exclusion of the form syn which, in adenosine, may attain a value of 35%.
Like the /?-furanosides, the /?-arabinofuranosides of benzimidazoles are conformationally "flexible", the conformer populations of the sugar ring and exocyclic group being analogous to those of aarabinosides of purines (I. Ekiel, in preparation). The results obtained in this study are, however, not adequate to establish unequivocally the conforma tion about the glycosidic bond, and this problem is being further pursued. X-ray diffraction data testify to the absence of a single rigid conformation, since in the solid state 5,6-dimethylbenzimidazole-a-D-ribofuranoside is in the syn conformation [19] , where as the same nucleoside, as a component of vitamin B12, is in the conformation anti [20] , while in both instances the sugar conformation is C(3')endo. Melting points (uncorr.) were measured on a Boetius microscope hot stage. Elementary analyses were performed on a Perkin-Elmer instrument Model 240 at the Institute of Organic Chemistry. Ultraviolet absorption spectra were run on a Zeiss (Jena, GDR) VSU-2 spectrophotometer.
Column chromatography was carried out with Servachrome (Heidelberg, GFR) XAD-4, 100-200 |i, and with Merck (Darmstadt, GFR) Kieselgel 60, 70-230 mesh. Thin-layer chromatography was with Merck silica gel 60 F254 and PF254 plates.
*H NMR spectra were recorded on a JEOL JNM 4H 100 and on a Brucker-90 at room temperature, using 0.2 M solutions in (C2H3)2SO or C2H30 2H, with (CH3)4Si as internal standard. The spectra of the 2-a-hydroxybenzyl derivative of benzimidazole riboside were kindly provided by Dr. W. Streicher of Sandoz Forschungsinstitut, Vienna. Chemical shifts were determined to an accuracy of 0.01 ppm and coupling constants to an accuracy of 0.2 Hz. The accuracy is slightly less in the case of the unresolved mixture of the 5-bromo-and 6-bromo-derivatives of benzimidazole riboside.
4,6-dibromo-and 5 ,7-dibromo-l-ß-D -rib o fu ra n o syl-
benzimidazole. A mixture of 2.70 g (9.4 mmol) of 4,6-dibromobenzimidazole, 8 ml hexamethyldisilazane and a crystal of (NH4)2S 0 4 was heated under reflux for 15 min. The solution was brought care fully to dryness and the residue taken up in 60 ml anhydrous ethylene chloride. To this was added 5.04 g (10 mmol) l-0-acetyl-2,3,5-tri-0-benzoyl-/?-D-ribofuranoside and 1.7 ml anhydrous SnCl4, and the mixture stirred for 24 h at room temperature. Chloroform (150 ml) was added followed by 100 ml of saturated NaHCOs, and the mixture vigorously shak en. The resulting emulsion was filtered through Celite-501. The organic phase was removed, washed twice with 100 ml water, and dried over anhydrous N a2S 0 4. It was then concentrated to small volume and loaded on a 40 x 5 cm column of silica gel. Elu tion was then performed with benzene, followed by 1 -* 5% acetone in benzene. The pooled fractions containing the blocked nucleosides were brought to dryness (foam), and the residue taken up in 100 ml methanolic 0.1 m NaOCH3, and heated under reflux for 30 min. The mixture was brought to dryness, and the residue taken to dryness several times from water to remove methyl benzoate. The residue was crystallized from aqueous methanol to yield 1.41 g (35%) of a mixture of the 4,6-dibromo-and 5,7-dibromoisomeric nucleosides in the ratio 7:3 (from !H NMR analysis).
A sample of the mixed isomers (120 mg) in 10 ml methanol was deposited on a 45 x 2 cm column of Servachrom XAD-4, and elution carried out with a linear gradient of water and 70% aqueous isopropanol (2 L). The nucleosides were eluted in an asym metric peak at about 60% isopropanol. The fractions from this peak were divided into three portions. The first two portions were pooled, brought to dryness, and the residue crystallized from a small volume of aqueous isopropanol to yield 60 mg of the hydrate of the 4,6-dibromo nucleoside in the form of needles, m.p. 183-185 °C. Elem. anal.: Calculated for C12H 120 4N2Br2 • H20 : C, 33.96%, H, 3.30%; N, 6.60%; Found: C, 33.91%; H, 3.28%; N, 6.66%.
The third portion of the peak was brought to dry ness and also crystallized from aqueous isopropanol to yield 45 mg of the hydrate of the 5,7-dibromo derivative in the form of needles, m .p. 159-162 °C. Elem. anal.: Calculated for C12H 120 4Br2 H20 : C, 33.96%; H, 3.30%; A, 6.60%; Found: C, 34.13%; H, 3.29%; N. 6.53%.
4,6-dibromo-l-( a-D-arabinofuranosyl)-benzimidazole.
A solution consisting of 3.48 g (10 mmol) of silylated 4,6-dibromobenzimidazole, 4.77g (10 mmol) of 1 -0-methyl-2,3,5-tri-0-benzoylarabinofuranose, and 3 ml (26 mmol) SnCl4 in 50 ml of 1,2-dichloroethane was refluxed for 6 h and then left overnight at room temperature. The reaction mixture was then worked up as for the synthesis of 4,6-dibromo-l-(ß-D-ribofuranosyl)-benzimidazole. The benzoylated nucleoside, contaminated with unreacted sugar, was dissolved in benzene and deposited on a column of 500 g of Merck (Darmstadt, G FR) Kieselgel 60, 70-230 mesh. Elution was carried out with benzene solutions of isopropanol with increasing concentra tions of the latter: 2% (500 ml), 5% (500 ml), and 10% (1000 ml), and collection of 25-ml fractions. The fractions containing the nucleoside (60-72) were pooled, brought to dryness under reduced pressure and debenzoylated in methanolic sodium methoxylate as above. The resulting solution was brought to neutrality with acetic acid and brought to dryness. The resulting oily residue was extracted several times with chloroform, and crystallized from aqueous ethanol to yield 612 mg (15%) of the free nucleoside in the form of fine needles, m.p. 189 -191 °C. Elem. anal.: Calculated for C12H12N 20 4Br2: C, 35.33%; H, 2.94%; N, 6.86%; Found: C, 35.24%; H, 2.81%; N, 6.71%. -2-m ethyl-l-ß-D -ribofuranosylbenzim id- azole. A mixture of 370 mg (1.95 mmol) of 5,6-dichloro-2-methylbenzimidazole [9], 1.05 g (2.1 mmol) 1 -0-acetyl-2,3,5-tn-0-benzoyl-/?-D-ribofuranose, and 10 mg of toluenosulfonic acid hydrate, was ground to a fine powder. The mixture was heated under vacuum (water pump) on an oil bath (1 6 0°-165 °C) for 40 min. The mixture was cooled, taken up in 10 ml chloroform, and subjected to chromato graphy on Merck PF254 silica gel plates with chloro form containing 1% methanol (R f of blocked nucleo side 0.60). The band corresponding to the nucleo side was eluted with a 1:1 mixture of chloroformisopropanol. The eluate was brought to dryness, and the residue taken up in 30 ml methanolic 0.1 m NaOCH3. This was heated under reflux for 15 min and then brought to dryness. The residue was taken up in 20 ml water, the solution brought to pH 5 with acetic acid, and brought to dryness several times from water to remove methyl benzoate. The final residue was dissolved in 20 ml hot water, and crystallized at room temperature to yield 160 mg 3 mmol) 5,6-dichloro-l-/?-D-ribofuranosylbenzimidazole in 25 ml ace tone and 5 ml 2,2-dimethoxypropane was added, portionwise and with constant stirring over the course of 1 h at room temperature, 2.1 g (11 mmol) /^-toluenosulfonic acid. Stirring was continued for an additional 2 h. The mixture was then poured into 150 ml water, the pH brought to 8 with triethylamine, followed by heating, and addition of 2 -3 ml methanol to produce a clear solution. Storage at room temperature led to formation of crystals in the form of needles, (1.05 g, 90% yield), chromatographically homogeneous. An analytical sample was ob tained by recrystallization from 33% aqueous meth-anol, m. p. 168° C. Elementary analysis: Calculated for C15H 15N20 4C12: C, 50.26%; H, 4.22%; N, 7.82%; Found: C, 49.94%; H, 4.33%; N, 7.76%.
5.6-dichloro
5,6-dichloro-l-(5-ch loro-5-deoxy-ß-D -ribofu ran osyl)
ben zim idazole. To a solution of 1.32 g (7 mmol) 5,6-dichloro-l-/?-D-ribofuranosylbenzimidazole in 13.5 ml of hexamethylphosphoric triamide was added 2.64 ml (36.5 mmol) freshly distilled thionyl chlo ride. Chromatography showed disappearance of start ing substance after 1 h at room temperature. The mixture was poured into 200 ml water and filtered. The filtrate was loaded on a 2 x 20 cm column of Dowex 50 W x 8 (H+), and the column washed with 500 ml of methanol-water-conc. N H 4OH 2:1:1, v/v).
The effluent was brought to dryness and the res idue crystallized from water to yield fine needles (0.94gm, 68%), m. 
